Dumbleton K, Caffery B, Dogru M, Hickson-Curran S, Kern J, Kojima T, et al. The TFOS international workshop on contact lens discomfort: report of the subcommittee on epidemiology. Invest Ophthalmol Vis Sci. 2013;54:TFOS20–36.
Yokoi N, Eftimov P, Georgiev GA. Dynamic aspects of pre-soft contact lens tear film and their relation to dry eye: Basic Science and Clinical Relevance. Life (Basel). 2023;13:859.
Osae EA, Jones L, Nichols JJ. The impact of contact lenses on meibomian gland morphology. Ocul Surf. 2022;24:148–55.
Colorado LH, Alzahrani Y, Pritchard N, Efron N. Time course of changes in goblet cell density in symptomatic and asymptomatic contact lens wearers. Invest Ophthalmol Vis Sci. 2016;57:2888–94.
Korb DR, Greiner JV, Herman JP, Hebert E, Finnemore VM, Exford JM, et al. Lid-wiper epitheliopathy and dry-eye symptoms in contact lens wearers. CLAO J. 2002;28:211–6.
Golding TR, Bruce AS, Mainstone JC. Relationship between tear-meniscus parameters and tear-film breakup. Cornea. 1997;16:649–61.
Article PubMed CAS Google Scholar
Chen Q, Wang J, Shen M, Cui L, Cai C, Li M, et al. Tear menisci and ocular discomfort during daily contact lens wear in symptomatic wearers. Invest Ophthalmol Vis Sci. 2011;52:2175–80.
Guillon M, Dumbleton KA, Theodoratos P, Wong S, Patel K, Banks G, et al. Association between contact lens discomfort and pre-lens tear film kinetics. Optom Vis Sci. 2016;93:881–91.
Itokawa T, Suzuki T, Iwashita H, Hori Y. Comparison and evaluation of prelens tear film stability by different noninvasive in vivo methods. Clin Ophthalmol. 2020;14:4459–68.
Article PubMed PubMed Central Google Scholar
Papas EB, Ciolino JB, Jacobs D, Miller WL, Pult H, Sahin A et al. The TFOS international workshop on contact lens discomfort: report of the management and therapy subcommittee. Invest Ophthalmol Vis Sci. 2013;54:TFOS183-203.
Fernández-Jimenez E, Diz-Arias E, Peral A. Improving ocular surface comfort in contact lens wearers. Cont Lens Anterior Eye. 2022;45:101544.
Matsumoto Y, Ohashi Y, Watanabe H, Tsubota K. Efficacy and safety of diquafosol ophthalmic solution in patients with dry eye syndrome: a Japanese phase 2 clinical trial. Ophthalmology. 2012;119:1954–60.
Koh S. Contact lens wear and dry eye: beyond the known. Asia Pac J Ophthalmol (Phila). 2020;9:498–504.
Cowlen MS, Zhang VZ, Warnock L, Moyer CF, Peterson WM, Yerxa BR. Localization of ocular P2Y2 receptor gene expression by in situ hybridization. Exp Eye Res. 2003;77:77–84.
Article PubMed CAS Google Scholar
Nakamura M, Imanaka T, Sakamoto A. Diquafosol ophthalmic solution for dry eye treatment. Adv Ther. 2012;29:579–89.
Article PubMed CAS Google Scholar
Yokoi N, Kato H, Kinoshita S. Facilitation of tear fluid secretion by 3% diquafosol ophthalmic solution in normal human eyes. Am J Ophthalmol. 2014;157:85–e921.
Article PubMed CAS Google Scholar
Nam KT, Ahn SM, Eom Y, Kim HM, Song JS. Immediate effects of 3% diquafosol and 0.1% hyaluronic acid ophthalmic solution on tear break-up time in normal human eyes. J Ocul Pharmacol Ther. 2015;31:631–5.
Article PubMed CAS Google Scholar
Nagahara Y, Koh S, Nishida K, Watanabe H. Prolonged increase in tear meniscus height by 3% diquafosol ophthalmic solution in eyes with contact lenses. Clin Ophthalmol. 2015;9:1029–31.
Article PubMed PubMed Central Google Scholar
Uchino M, Yokoi N, Shimazaki J, Hori Y, Tsubota K. On behalf of the Japan dry eye society. Adherence to eye drops usage in dry eye patients and reasons for non-compliance: a web-based survey. J Clin Med. 2022;11:367.
Article PubMed PubMed Central Google Scholar
Hori Y, Oka K, Inai M. Efficacy and safety of the long-acting diquafosol ophthalmic solution DE-089 C in patients with dry eye: a randomized, double-masked, placebo-controlled phase 3 study. Adv Ther. 2022;39:3654–67.
Article PubMed PubMed Central CAS Google Scholar
Ishikawa S, Sasaki T, Maruyama T, Murayama K, Shinoda K. Effectiveness and adherence of dry eye patients who switched from short- to long-acting diquafosol ophthalmic solution. J Clin Med. 2023;12:4495.
Article PubMed PubMed Central CAS Google Scholar
Baek J, Doh SH, Chung SK. Comparison of tear meniscus height measurements obtained with the keratograph and Fourier domain optical coherence tomography in dry eye. Cornea. 2015;34:1209–13.
Itokawa T, Okajima Y, Suzuki T, Kakisu K, Iwashita H, Murakami Y, et al. Association between ocular surface temperature and tear film stability in soft contact lens wearers. Invest Ophthalmol Vis Sci. 2018;59:771–5.
Article PubMed CAS Google Scholar
Itokawa T, Okajima Y, Iwashita H, Koji K, Suzuki T, Hori Y. Association between mask-associated dry eye (MADE) and corneal sensations. Sci Rep. 2023;13:1625.
Article PubMed PubMed Central CAS Google Scholar
Itokawa T, Suzuki T, Koh S, Hori Y. Evaluating the differences between fluorescein tear break-up time and noninvasive measurement techniques. Eye Contact Lens. 2023;49:104–9.
Midorikawa-Inomata A, Inomata T, Nojiri S, Nakamura M, Iwagami M, Fujimoto K et al. Reliability and validity of the Japanese version of the ocular surface disease index for dry eye disease. BMJ Open. 2019;9: e033940.
Koh S, Chalmers R, Kabata D, Shintani A, Nishida K. Translation and validation of the 8-item contact lens dry eye questionnaire (CLDEQ-8) among Japanese soft contact lens wearers: the J-CLDEQ-8. Cont Lens Anterior Eye. 2019;42:533–9.
Yerxa BR, Douglass JG, Elena PP, Caillaud T, Amar T, Edick C, et al. Potency and duration of action of synthetic P2Y2 receptor agonists on Schirmer scores in rabbits. Adv Exp Med Biol. 2002;506:261–5.
Article PubMed CAS Google Scholar
Shichijo Y, Murakami T, Nakamura M. Stimulatory effect of diquafosol tetrasodium on tear fluid secretion in normal rabbits. J Eye. 2011;28:1029–33. (in Japanese).
Hori Y, Maeno T. Effects of diquafosol ophthalmic solutions and rebamipide ophthalmic suspension on tear fluid volume in normal rabbits. J Eye. 2013;30:1007–10. (in Japanese).
Hori Y. Secreted mucins on the ocular surface. Invest Ophthalmol Vis Sci. 2018;59:DES151–6.
Article PubMed CAS Google Scholar
Fujihara T, Murakami T, Fujita H, Nakamura M, Nakata K. Improvement of corneal barrier function by the P2Y(2) agonist INS365 in a rat dry eye model. Invest Ophthalmol Vis Sci. 2001;42:96–100.
Shichijo Y, Sakamoto A, Nakamura M. Effect of diquafosol tetrasodium on MUC5AC secretion by rabbit conjunctival tissues. J Eye. 2011;28:261–5. (in Japanese).
Shigeyasu C, Hirano S, Akune Y, Yamada M. Diquafosol tetrasodium increases the concentration of mucin-like substances in tears of healthy human subjects. Curr Eye Res. 2015;40:878–83.
Article PubMed CAS Google Scholar
Akiyama-Fukuda R, Usui T, Yoshida T, Yamagami S. Evaluation of tear meniscus dynamics using anterior segment swept-source optical coherence tomography after topical solution instillation for dry eye. Cornea. 2016;35:654–8.
Itokawa T, Iwashita H, Okajima Y, Suzuki T, Hori Y. Changes in ocular surface temperature after instillation of 3% diquafosol ophthalmic solution over soft contact lenses. J Japan Contact Lens Soc. 2018;60:91–5. (in Japanese).
Comments (0)